1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Radiopharmaceuticals Market – By Type

1.3.2        APAC Radiopharmaceuticals Market – By Application

1.3.3        APAC Radiopharmaceuticals Market – By End User

1.3.4        APAC Radiopharmaceuticals Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Radiopharmaceuticals Market– Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Radiopharmaceuticals Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2        Escalating Advancements in Nuclear Imaging Techniques

5.2         Market Restraints

5.2.1        Presence of Alternatives

5.3         Market Opportunities

5.3.1        Soaring Growth in Emerging Countries

5.4         Future Trends

5.4.1        Rising Use of Nuclear Medicines for Personalized Treatment

5.5         Impact Analysis

6.           Radiopharmaceuticals Market– APAC Analysis

6.1         APAC Radiopharmaceuticals Market Revenue Forecast and Analysis

7.           APAC Radiopharmaceuticals Market Analysis – By Type

7.1         Overview

7.2         APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Nuclear Medicine

7.3.1        Overview

7.3.2        Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        SPECT

7.3.3.1          Overview

7.3.3.2          SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        PET

7.3.4.1          Overview

7.3.4.2          PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Therapeutic Nuclear Medicine

7.4.1        Overview

7.4.2        Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Alpha Emitters

7.4.3.1          Overview

7.4.3.2          Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Beta Emitters

7.4.4.1          Overview

7.4.4.2          Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Brachytherapy Isotopes

7.4.5.1          Overview

7.4.5.2          Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Radiopharmaceuticals Market Analysis – By Application

8.1         Overview

8.2         APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3         Oncology

8.3.1        Overview

8.3.2        Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Cardiology

8.4.1        Overview

8.4.2        Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurology

8.5.1        Overview

8.5.2        Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Radiopharmaceuticals Market Analysis – By End User

9.1         Overview

9.2         APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Imaging Centres

9.4.1        Overview

9.4.2        Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Centers

9.5.1        Overview

9.5.2        Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.        APAC Radiopharmaceuticals Market – Country Analysis

10.1      APAC: Radiopharmaceuticals Market

10.1.1     Overview

10.1.2     APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1       China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1     China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2     China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3       China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4       China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2       Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1     Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2     Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3       Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4       Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3       India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1     India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2     India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3       India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4       India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4       Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1     Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2     Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3       Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4       Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5       South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1       South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2       South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1     South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2     South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3       South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4       South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6       Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1       Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2       Rest of APAC: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1     Rest of APAC: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2     Rest of APAC: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3       Rest of APAC: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4       Rest of APAC: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on APAC Radiopharmaceuticals Market

11.1      APAC: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Cardinal Health Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Curium

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GENERAL ELECTRIC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Lantheus Medical Imaging, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bayer AG

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bracco Imaging S.p.A

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ECZACIBAI MONROL NUCLEAR PRODUCTS CO.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Nordion

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      NTP RADIOISOTOPES

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Advanced Accelerator Applications

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             APAC Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4.             China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14.          India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15.          India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19.          Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21.          Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22.          South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24.          South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25.          South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26.          South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of APAC: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of APAC Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of APAC Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of APAC: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of APAC: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32.          Recent Inorganic Growth Strategies

Table 33.          Recent Organic Growth Strategies

Table 34.          Glossary of Terms

Figure 1.           APAC Radiopharmaceuticals Market Segmentation

Figure 2.           APAC Radiopharmaceuticals Market Segmentation, By Country

Figure 3.           APAC Radiopharmaceuticals Market Overview

Figure 4.           Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5.           India to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           APAC Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8.           APAC Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9.           APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10.        APAC Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        APAC SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        APAC PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        APAC Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        APAC Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        APAC Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18.        APAC Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        APAC Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        APAC Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23.        APAC Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        APAC Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        APAC: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.        APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29.        China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Impact of COVID-19 Pandemic in APAC Country Markets